Back to top
more

Geron (GERN)

(Delayed Data from NSDQ)

$1.28 USD

1.28
11,318,845

-0.02 (-1.54%)

Updated Aug 8, 2025 04:00 PM ET

After-Market: $1.29 +0.01 (0.78%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth A Momentum D VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 40% (147 out of 244)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Mallinckrodt Initiates Amyotrophic Lateral Sclerosis Study

by Zacks Equity Research

Mallinckrodt plc (MNK) announced that it has enrolled the first patient in its phase IIB study, PENNANT.

    Zacks Equity Research

    Omeros (OMER) Hits New 52-Week High on Positive FDA Decision

    by Zacks Equity Research

    Omeros Corporation (OMER) shares hit a new 52-week high of $22.80 on Thursday before eventually closing at $22.15.

      Zacks Equity Research

      Geron (GERN) Up 3.1% Since Earnings Report: Can It Continue?

      by Zacks Equity Research

      Geron (GERN) reported earnings 30 days ago. What's next for the company? We take a look at earnings estimates for some clues.

        Zacks Equity Research

        Geron Corp (GERN) Worth a Look: Stock Adds 7% in Session

        by Zacks Equity Research

        Geron Corporation (GERN) shares rose over 7% in the last trading session.

          Zacks Equity Research

          Geron (GERN) Q1 Loss In Line, Focus Remains on Imetelstat

          by Zacks Equity Research

          Geron Corporation (GERN) reported a loss of 5 cents per share in the first quarter of 2017, in line with the Zacks Consensus Estimate. In the year-ago quarter.

            Zacks Equity Research

            Geron (GERN) Q1 Earnings: What's in Store for the Stock?

            by Zacks Equity Research

            Geron Corporation (GERN) is expected to report first-quarter 2017 results next week

              Zacks Equity Research

              Will Geron (GERN) Continue to Surge Higher?

              by Zacks Equity Research

              As of late, it has definitely been a great time to be an investor in Geron Corporation (GERN).

                Zacks Equity Research

                Top Ranked Momentum Stocks to Buy for April 18th

                by Zacks Equity Research

                Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 18th:

                  Arpita Dutt headshot

                  Biotech Stock Roundup: Geron Gains on Interim Data, OncoMed Slumps on Pipeline Setback

                  by Arpita Dutt

                  Key highlights this week included pipeline updates from companies like Geron (GERN) and OncoMed.

                    Zacks Equity Research

                    Geron Stock Rises after Positive Interim Update on Imetelstat

                    by Zacks Equity Research

                    Shares of Geron Corporation (GERN) increased almost 20% on Monday after it provided a positive update on two late-stage studies for imetelstat, its lead pipeline candidate.

                      Zacks Equity Research

                      Geron (GERN) Q4 Loss Narrows; Focus Remains on Imetelstat

                      by Zacks Equity Research

                      Geron Corporation (GERN) reported a loss of 5 cents per share in the fourth quarter of 2016, flat year over year but narrower than the Zacks Consensus Estimate of a loss of 6 cents.

                        Zacks Equity Research

                        Drug Stocks Q4 Earnings Lineup for Mar 1: MYL, KERX & More

                        by Zacks Equity Research

                        With the curtains almost down on the Q4 earnings season, we believe this quarter has turned out to be a good one with growth on track to be the highest in the last two years.

                          Zacks Equity Research

                          Geron (GERN) Q4 Earnings: What's in Store for the Stock?

                          by Zacks Equity Research

                          Geron Corporation (GERN) is expected to report fourth-quarter 2016 results next week. In the last reported quarter, the company recorded a positive earnings surprise of 66.67%.